Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Akcılar, F. Kocak, Hasan Şimşek, Aydın Akçılar, Z. Bayat, Ezgi Ece, Hülya Kökdaşgil (2016)
Antidiabetic and hypolipidemic effects of adropinin streoptozotocin-induced type 2 diabetic rats.Bratislavske lekarske listy, 117 2
C. Williams, Joel Stengel, Michael Asike, D. Torres, J. Shaw, M. Contreras, Cristy Landt, S. Harrison (2011)
Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study.Gastroenterology, 140 1
K. Mather, A. Lteif, H. Steinberg, A. Baron (2004)
Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.Diabetes, 53 8
Aijaz Ahmed, R. Wong, S. Harrison (2015)
Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 13 12
K. Kumar, James Trevaskis, Daniel Lam, Gregory Sutton, Robert Koza, V. Chouljenko, Konstantin Kousoulas, Pamela Rogers, Robert Kesterson, M. Thearle, Anthony Ferrante, R. Mynatt, Thomas Burris, J. Dong, H. Halem, M. Culler, Lora Heisler, Jacqueline Stephens, Andrew Butler (2008)
Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism.Cell metabolism, 8 6
A. Lian, Keqiang Wu, Tianqiang Liu, N. Jiang, Q. Jiang (2016)
Adropin induction of lipoprotein lipase expression in tilapia hepatocytes.Journal of molecular endocrinology, 56 1
M. Topuz, A. Çelik, Tutku Aslantas, A. Demir, S. Aydin, S. Aydin (2013)
Plasma Adropin Levels Predict Endothelial Dysfunction Like Flow-Mediated Dilatation in Patients With Type 2 Diabetes MellitusJournal of Investigative Medicine, 61
H. Kitade, Guanliang Chen, Y. Ni, Tsuguhito Ota (2017)
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New TreatmentsNutrients, 9
Quinn Sf, B. Gosink (1985)
Characteristic sonographic signs of hepatic fatty infiltration.AJR. American journal of roentgenology, 145 4
K. Ganesh‐Kumar, Jingying Zhang, Su Gao, Jari Rossi, O. McGuinness, Heather Halem, M. Culler, R. Mynatt, A. Butler (2012)
Adropin Deficiency Is Associated With Increased Adiposity and Insulin ResistanceObesity, 20
H. Tilg, A. Moschen (2010)
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesisHepatology, 52
S. Tyagi, Paras Gupta, Arminder Saini, Chaitnya Kaushal, Saurabh Sharma (2011)
The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseasesJournal of Advanced Pharmaceutical Technology & Research, 2
Ling-zhen Wu, J. Fang, Lianglong Chen, Ziwen Zhao, Yukun Luo, Chao-gui Lin, L. Fan (2014)
Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patientsClinical Chemistry and Laboratory Medicine, 52
M. St-Onge, A. Shechter, J. Shlisky, C. Tam, Su Gao, E. Ravussin, A. Butler (2013)
Fasting plasma adropin concentrations correlate with fat consumption in human femalesObesity (Silver Spring, Md.), 22
Wenchao Hu, Li Chen (2016)
Association of Serum Adropin Concentrations with Diabetic NephropathyMediators of Inflammation, 2016
Oya Sayın, Y. Tokgöz, N. Arslan (2014)
Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver diseaseJournal of Pediatric Endocrinology and Metabolism, 27
C. McClain, S. Mokshagundam, S. Barve, Zhenyuan Song, D. Hill, Theresa Chen, I. Deaciuc (2004)
Mechanisms of non-alcoholic steatohepatitis.Alcohol, 34 1
Su Gao, R. McMillan, Qingzhang Zhu, G. Lopaschuk, M. Hulver, A. Butler (2015)
Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistanceMolecular Metabolism, 4
Agata Mierzwicka, M. Bolanowski (2016)
New peptides players in metabolic disorders.Postepy higieny i medycyny doswiadczalnej, 70 0
L. Abenavoli, N. Milić, L. Renzo, T. Preveden, M. Medic-Stojanoska, A. Lorenzo (2016)
Metabolic aspects of adult patients with nonalcoholic fatty liver disease.World journal of gastroenterology, 22 31
M. Kałużna, K. Hoppe, K. Schwermer, A. Ibrahim, K. Pawlaczyk, K. Ziemnicka (2016)
Adropin and irisin levels in relation to nutrition, body composition, and insulin resistance in patients with end-stage renal disease on chronic hemodialysis and peritoneal dialysis.Polskie Archiwum Medycyny Wewnetrznej, 126 7-8
S. Baka, A. Malamitsi‐Puchner, D. Briana, M. Boutsikou, A. Marmarinos, D. Gourgiotis, T. Boutsikou (2015)
Adropin concentrations in term pregnancies with normal, restricted and increased fetal growthThe Journal of Maternal-Fetal & Neonatal Medicine, 29
Joel Haas, S. Francque, B. Staels (2016)
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease.Annual review of physiology, 78
T. Kume, M. Çalan, Ö. Yılmaz, G. Kocabas, P. Yeşil, M. Temur, M. Biçer, O. Calan (2016)
A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndromeJournal of Endocrinological Investigation, 39
R. Loomba, M. Abraham, A. Unalp, L. Wilson, J. Lavine, E. Doo, N. Bass (2012)
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosisHepatology, 56
F. Lovren, Yi Pan, A. Quan, Krishna Singh, P. Shukla, M. Gupta, M. Al-Omran, H. Teoh, S. Verma (2010)
Adropin Is a Novel Regulator of Endothelial FunctionCirculation, 122
S. Verma, M. Buchanan, T. Anderson (2003)
Endothelial function testing as a biomarker of vascular disease.Circulation, 108 17
A. Butler, C. Tam, K. Stanhope, B. Wolfe, M. Ali, M. O’keeffe, M. St-Onge, E. Ravussin, P. Havel (2012)
Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans.The Journal of clinical endocrinology and metabolism, 97 10
Hong Wang, R. Eckel (2009)
Lipoprotein lipase: from gene to obesity.American journal of physiology. Endocrinology and metabolism, 297 2
Jin‐Biou Chang, N. Chu, Fu-Huang Lin, Jhu-Ting Hsu, Pi-Yun Chen (2017)
Relationship between plasma adropin levels and body composition and lipid characteristics amongst young adolescents in Taiwan.Obesity research & clinical practice, 12 Suppl 2
S. Aydin, T. Kuloğlu, S. Aydin, M. Eren, M. Yılmaz, M. Kalaycı, I. Sahin, N. Kocaman, Cihan Çitil, Yalcin Kendir (2013)
Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetesMolecular and Cellular Biochemistry, 380
Objectives: Adropin is a novel marker of metabolic syndrome and insulin resistance. The aim of this study was to explore the association of serum adropin levels with hepatosteatosis among adult patients. Materials and Methods: Serum biochemical parameters including liver and renal function tests, insulin levels, and serum adropin levels were compared between adult patients with nonalcoholic fatty liver disease (NAFLD) and healthy control cases. Results: A total of 51 patients with a mean age of 37.9 ± 9.96 years diagnosed with grade 2–3 hepatosteatosis and 30 healthy control cases with a mean age of 34.8 ± 9.5 years were included in the study. Serum adropin levels in the NAFLD group were statistically significantly lower than in the control cases (588.4 ± 261.0 vs. 894.2 ± 301.2, respectively; p < 0.001). The study participants were further subdivided into 2 groups as patients with (n = 35) or without (n = 46) insulin resistance using the serum homeostatic model of assessment-insulin resistance (HOMA-IR). Serum adropin levels were statistically significantly lower in patients with insulin resistance (p < 0.01). There was a negative correlation between adropin levels and serum insulin, HOMA-IR, urea, gamma-glutamyl transferase, total cholesterol, and triglyceride levels. Conclusion: We observed a decrease in serum adropin levels among adult patients with NAFLD. We also found lower levels of serum adropin in patients with insulin resistance, supporting previous data in the literature. Studies investigating the association of adropin levels with other inflammatory parameters are warranted to define its exact role in the pathogenesis of hepatosteatosis.
Medical Principles and Practice – Karger
Published: Jan 1, 2019
Keywords: Hepatosteatosis; Adropin; Liver disease
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.